STXV - ETF AI Analysis
Top Page
Strive 1000 Value ETF (STXV)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and in recent months, showing positive momentum for investors.
Leading Blue-Chip Holdings
Many of the top positions, including major energy, financial, and health care companies, have shown strong or steady performance, helping support the fund’s returns.
Broad Sector Diversification
Holdings spread across financials, health care, energy, technology, and several other sectors help reduce the impact if any one industry struggles.
Negative Factors
Heavy U.S. Concentration
The fund is overwhelmingly invested in U.S. companies, offering very limited diversification across other countries.
Sector Tilts Toward Financials and Health Care
Large weights in financial and health care stocks mean the ETF could be more sensitive if those sectors face a downturn.
Mixed Performance Among Top Holdings
While many top holdings are performing well, at least one major position has been weak, which can drag on overall results.
STXV vs. SPDR S&P 500 ETF (SPY)
AUM76.40M
RegionNorth America
Expense Ratio0.18%
Beta0.59
IssuerStrive
Inception DateNov 10, 2022
Dividend Yield2.12%
Asset ClassEquity
Index TrackedBloomberg US 1000 Value
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,867
30 Day Avg. Volume9,944
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
44.65Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering701
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
STXV Summary
The Strive 1000 Value ETF (STXV) tracks the Bloomberg US 1000 Value index, focusing on large U.S. companies that appear undervalued based on their fundamentals. It owns a wide mix of sectors, with big names like Exxon Mobil and Bank of America among its top holdings. Someone might invest in this ETF to get broad, diversified exposure to established companies that may offer both growth and income over time. A key risk is that value stocks can fall out of favor, so the ETF’s price can go up and down with shifts in the overall stock market and investor sentiment.
How much will it cost me?The Strive 1000 Value ETF (Ticker: STXV) has an expense ratio of 0.18%, which means you’ll pay $1.80 per year for every $1,000 invested. This is lower than the average for actively managed funds because it is passively managed, tracking an index of large-cap value stocks.
What would affect this ETF?The Strive 1000 Value ETF could benefit from a favorable economic environment that supports value investing, such as rising interest rates, which often boost financial sector performance, or increased demand for energy and healthcare services, given its significant exposure to these sectors. However, challenges like regulatory changes affecting top holdings like Exxon Mobil or Johnson & Johnson, or economic slowdowns that impact consumer spending and cyclical sectors, could negatively affect the ETF's performance.
STXV Top 10 Holdings
STXV leans heavily into classic U.S. value names, with energy and financial giants setting the tone. Exxon and Chevron have been rising, giving the fund a solid tailwind as energy stays in favor, while Merck’s steady strength in health care adds defensive balance. On the flip side, big banks like Bank of America and Wells Fargo have been lagging, acting as a brake on returns. Staples leader Procter & Gamble and telecom player Verizon are more steady contributors, helping smooth out the ride in this broadly diversified, large-cap value portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 4.23% | $3.20M | $727.85B | 57.88% | 74 Outperform | |
| Chevron | 2.44% | $1.85M | $438.70B | 44.56% | 71 Outperform | |
| Bank of America | 1.95% | $1.47M | $359.36B | 2.50% | 72 Outperform | |
| Wells Fargo | 1.41% | $1.07M | $242.83B | -1.49% | 80 Outperform | |
| UnitedHealth | 1.37% | $1.04M | $355.11B | 14.02% | 72 Outperform | |
| Procter & Gamble | 1.28% | $970.96K | $363.57B | 5.00% | 69 Neutral | |
| Berkshire Hathaway B | 1.19% | $899.53K | $1.13T | 7.54% | 66 Neutral | |
| Merck & Company | 1.18% | $890.56K | $363.59B | 73.01% | 80 Outperform | |
| AbbVie | 1.17% | $883.89K | $500.94B | 24.92% | 66 Neutral | |
| SanDisk Corp | 1.14% | $861.65K | $202.82B | 866.82% | 55 Neutral |
STXV Technical Analysis
Positive
―
Price Trends
38.83
Positive
38.33
Positive
36.80
Positive
Market Momentum
<0.01
Negative
64.14
Neutral
94.45
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For STXV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 38.19, equal to the 50-day MA of 38.83, and equal to the 200-day MA of 36.80, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 64.14 is Neutral, neither overbought nor oversold. The STOCH value of 94.45 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for STXV.
STXV Peer Comparison
Comparison Results
Performance Comparison
STXV
Strive 1000 Value ETF
39.06
7.62
24.24%
MAVF
Matrix Advisors Value ETF
―
―
―
PRXV
Praxis Impact Large Cap Value ETF
―
―
―
NSIV
North Square Disciplined Value ETF
―
―
―
PZLV
Pzena U.S. Large Cap Value ETF
―
―
―
DHLX
Diamond Hill Large Cap Concentrated ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents